🇺🇸 FDA
Patent

US 9919058

Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer

granted A61KA61K31/4745A61K31/475

Quick answer

US patent 9919058 (Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/4745, A61K31/475, A61K31/7088, A61K31/711